As a case study in the proliferation of global rankings, this article examines the initiation, construction of, and response to the Access to Medicine Index, which ranks pharmaceutical companies according to their respective contribution to access to medicine for developing countries. Since it has served as the model for constructing global rankings in the fields of nutrition, seeds, and, possibly in the future, mining and oil, its significance goes well beyond public health.
Read the article
Published in Business and Politics
